HEADER SUGAR BINDING PROTEIN 12-SEP-03 1ULD TITLE CGL2 IN COMPLEX WITH BLOOD GROUP H TYPE II COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: CGL2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: COPRINOPSIS CINEREA; SOURCE 3 ORGANISM_TAXID: 5346; SOURCE 4 GENE: CGL2; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SEY 6210; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PYADE4 KEYWDS GALECTIN, LECTIN, BETA-GALACTOSIDE BINDING LECTIN, SUGAR BINDING, KEYWDS 2 SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.J.WALSER,P.W.HAEBEL,M.KUENZLER,U.KUES,M.AEBI,N.BAN REVDAT 6 03-APR-24 1ULD 1 REMARK REVDAT 5 27-DEC-23 1ULD 1 HETSYN REVDAT 4 29-JUL-20 1ULD 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1ULD 1 VERSN REVDAT 2 24-FEB-09 1ULD 1 VERSN REVDAT 1 20-APR-04 1ULD 0 JRNL AUTH P.J.WALSER,P.W.HAEBEL,M.KUENZLER,D.SARGENT,U.KUES,M.AEBI, JRNL AUTH 2 N.BAN JRNL TITL STRUCTURE AND FUNCTIONAL ANALYSIS OF THE FUNGAL GALECTIN JRNL TITL 2 CGL2 JRNL REF STRUCTURE V. 12 689 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 15062091 JRNL DOI 10.1016/J.STR.2004.03.002 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.T.BRUNGER,P.D.ADAMS,G.M.CLORE,W.L.DELANO,P.GROS, REMARK 1 AUTH 2 R.W.GROSSE-KUNSTLEVE,J.S.JIANG,J.KUSZEWSKI,M.NILGES, REMARK 1 AUTH 3 N.S.PANNU,R.J.READ,L.M.RICE,T.SIMONSON,G.L.WARREN REMARK 1 TITL CRYSTALLOGRAPHY & NMR SYSTEM: A NEW SOFTWARE SUITE FOR REMARK 1 TITL 2 MACROMOLECULAR STRUCTURE DETERMINATION. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 905 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444998003254 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 51209 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2582 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5654 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 320 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 339 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.78000 REMARK 3 B22 (A**2) : 3.78000 REMARK 3 B33 (A**2) : -7.56000 REMARK 3 B12 (A**2) : 3.37000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.320 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.970 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.870 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 50.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ULD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000005954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51209 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080 REMARK 200 RESOLUTION RANGE LOW (A) : 49.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: CGL2-LACTOSE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, PEG 400, SODIUM PHOSPHATE, REMARK 280 SODIUM CHLORIDE, PH 7.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.77633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.55267 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 81.55267 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.77633 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: 2 GALECTIN TETRAMERS IS FROM CRYSTALLOGRAPHIC DIMERS BY REMARK 300 -Y, -X, 2/3-Z REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 10600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 56.80650 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 98.39174 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 81.55267 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 81.55267 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 20 -19.84 89.16 REMARK 500 ARG A 66 147.32 175.54 REMARK 500 PHE A 104 -161.42 -104.43 REMARK 500 ALA A 127 135.73 -173.59 REMARK 500 GLU B 20 -14.92 87.23 REMARK 500 ARG B 66 142.80 -171.06 REMARK 500 ALA B 81 64.04 21.52 REMARK 500 PHE B 104 -162.74 -105.64 REMARK 500 ALA B 127 139.21 -177.19 REMARK 500 GLU C 20 -17.41 86.32 REMARK 500 ARG C 66 146.57 -171.29 REMARK 500 LYS C 68 -38.92 -36.86 REMARK 500 GLU C 82 54.71 37.43 REMARK 500 ASN C 88 70.27 -118.80 REMARK 500 PHE C 104 -159.28 -102.88 REMARK 500 ALA C 127 140.58 176.71 REMARK 500 GLU D 20 -23.34 91.15 REMARK 500 LYS D 33 46.56 -96.65 REMARK 500 PHE D 104 -156.34 -104.25 REMARK 500 ALA D 127 138.38 175.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SLA RELATED DB: PDB REMARK 900 MAMMALIAN HOMOLOGUE GALECTIN-1 WITH BIANTENNARY OLIGOSACCHARIDE REMARK 900 RELATED ID: 1QMJ RELATED DB: PDB REMARK 900 AVIAN HOMOLOGUE CG-16 REMARK 900 RELATED ID: 1GAN RELATED DB: PDB REMARK 900 AMPHIBIAN HOMOLOGUE GALECTIN-1 WITH N-ACETYLLACTOSAMINE REMARK 900 RELATED ID: 1C1F RELATED DB: PDB REMARK 900 FISH HOMOLOGUE CONGERIN I REMARK 900 RELATED ID: 1BKZ RELATED DB: PDB REMARK 900 MAMMALIAN HOMOLOGUE GALECTIN-7 REMARK 900 RELATED ID: 1A3K RELATED DB: PDB REMARK 900 MAMMALIAN HOMOLOGUE GALECTIN-3 CARBOHYDRATE BINDING DOMAIN REMARK 900 RELATED ID: 1LCL RELATED DB: PDB REMARK 900 MAMMALIAN CHARCOT-LEYDEN PROTEIN REMARK 900 RELATED ID: 1IS5 RELATED DB: PDB REMARK 900 FISH HOMOLOGUE CONGERIN II REMARK 900 RELATED ID: 1UL9 RELATED DB: PDB REMARK 900 1UL9 CONTAINS THE SAME PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 1ULC RELATED DB: PDB REMARK 900 1ULC CONTAINS THE SAME PROTEIN COMPLEXED WITH LACTOSE REMARK 900 RELATED ID: 1ULE RELATED DB: PDB REMARK 900 1ULE CONTAINS THE SAME PROTEIN COMPLEXED WITH LINEAR B2 REMARK 900 TRISACCHARIDE REMARK 900 RELATED ID: 1ULF RELATED DB: PDB REMARK 900 1ULF CONTAINS THE SAME PROTEIN COMPLEXED WITH BLOOD GROUP A REMARK 900 TETRASACCHARIDE REMARK 900 RELATED ID: 1ULG RELATED DB: PDB REMARK 900 1ULG CONTAINS THE SAME PROTEIN COMPLEXED WITH THOMSEN-FRIEDENREICH REMARK 900 ANTIGEN DBREF 1ULD A 1 150 GB 6983931 AAF34732 1 150 DBREF 1ULD B 1 150 GB 6983931 AAF34732 1 150 DBREF 1ULD C 1 150 GB 6983931 AAF34732 1 150 DBREF 1ULD D 1 150 GB 6983931 AAF34732 1 150 SEQRES 1 A 150 MET LEU TYR HIS LEU PHE VAL ASN ASN GLN VAL LYS LEU SEQRES 2 A 150 GLN ASN ASP PHE LYS PRO GLU SER VAL ALA ALA ILE ARG SEQRES 3 A 150 SER SER ALA PHE ASN SER LYS GLY GLY THR THR VAL PHE SEQRES 4 A 150 ASN PHE LEU SER ALA GLY GLU ASN ILE LEU LEU HIS ILE SEQRES 5 A 150 SER ILE ARG PRO GLY GLU ASN VAL ILE VAL PHE ASN SER SEQRES 6 A 150 ARG LEU LYS ASN GLY ALA TRP GLY PRO GLU GLU ARG ILE SEQRES 7 A 150 PRO TYR ALA GLU LYS PHE ARG PRO PRO ASN PRO SER ILE SEQRES 8 A 150 THR VAL ILE ASP HIS GLY ASP ARG PHE GLN ILE ARG PHE SEQRES 9 A 150 ASP TYR GLY THR SER ILE TYR TYR ASN LYS ARG ILE LYS SEQRES 10 A 150 GLU ASN ALA ALA ALA ILE ALA TYR ASN ALA GLU ASN SER SEQRES 11 A 150 LEU PHE SER SER PRO VAL THR VAL ASP VAL HIS GLY LEU SEQRES 12 A 150 LEU PRO PRO LEU PRO PRO ALA SEQRES 1 B 150 MET LEU TYR HIS LEU PHE VAL ASN ASN GLN VAL LYS LEU SEQRES 2 B 150 GLN ASN ASP PHE LYS PRO GLU SER VAL ALA ALA ILE ARG SEQRES 3 B 150 SER SER ALA PHE ASN SER LYS GLY GLY THR THR VAL PHE SEQRES 4 B 150 ASN PHE LEU SER ALA GLY GLU ASN ILE LEU LEU HIS ILE SEQRES 5 B 150 SER ILE ARG PRO GLY GLU ASN VAL ILE VAL PHE ASN SER SEQRES 6 B 150 ARG LEU LYS ASN GLY ALA TRP GLY PRO GLU GLU ARG ILE SEQRES 7 B 150 PRO TYR ALA GLU LYS PHE ARG PRO PRO ASN PRO SER ILE SEQRES 8 B 150 THR VAL ILE ASP HIS GLY ASP ARG PHE GLN ILE ARG PHE SEQRES 9 B 150 ASP TYR GLY THR SER ILE TYR TYR ASN LYS ARG ILE LYS SEQRES 10 B 150 GLU ASN ALA ALA ALA ILE ALA TYR ASN ALA GLU ASN SER SEQRES 11 B 150 LEU PHE SER SER PRO VAL THR VAL ASP VAL HIS GLY LEU SEQRES 12 B 150 LEU PRO PRO LEU PRO PRO ALA SEQRES 1 C 150 MET LEU TYR HIS LEU PHE VAL ASN ASN GLN VAL LYS LEU SEQRES 2 C 150 GLN ASN ASP PHE LYS PRO GLU SER VAL ALA ALA ILE ARG SEQRES 3 C 150 SER SER ALA PHE ASN SER LYS GLY GLY THR THR VAL PHE SEQRES 4 C 150 ASN PHE LEU SER ALA GLY GLU ASN ILE LEU LEU HIS ILE SEQRES 5 C 150 SER ILE ARG PRO GLY GLU ASN VAL ILE VAL PHE ASN SER SEQRES 6 C 150 ARG LEU LYS ASN GLY ALA TRP GLY PRO GLU GLU ARG ILE SEQRES 7 C 150 PRO TYR ALA GLU LYS PHE ARG PRO PRO ASN PRO SER ILE SEQRES 8 C 150 THR VAL ILE ASP HIS GLY ASP ARG PHE GLN ILE ARG PHE SEQRES 9 C 150 ASP TYR GLY THR SER ILE TYR TYR ASN LYS ARG ILE LYS SEQRES 10 C 150 GLU ASN ALA ALA ALA ILE ALA TYR ASN ALA GLU ASN SER SEQRES 11 C 150 LEU PHE SER SER PRO VAL THR VAL ASP VAL HIS GLY LEU SEQRES 12 C 150 LEU PRO PRO LEU PRO PRO ALA SEQRES 1 D 150 MET LEU TYR HIS LEU PHE VAL ASN ASN GLN VAL LYS LEU SEQRES 2 D 150 GLN ASN ASP PHE LYS PRO GLU SER VAL ALA ALA ILE ARG SEQRES 3 D 150 SER SER ALA PHE ASN SER LYS GLY GLY THR THR VAL PHE SEQRES 4 D 150 ASN PHE LEU SER ALA GLY GLU ASN ILE LEU LEU HIS ILE SEQRES 5 D 150 SER ILE ARG PRO GLY GLU ASN VAL ILE VAL PHE ASN SER SEQRES 6 D 150 ARG LEU LYS ASN GLY ALA TRP GLY PRO GLU GLU ARG ILE SEQRES 7 D 150 PRO TYR ALA GLU LYS PHE ARG PRO PRO ASN PRO SER ILE SEQRES 8 D 150 THR VAL ILE ASP HIS GLY ASP ARG PHE GLN ILE ARG PHE SEQRES 9 D 150 ASP TYR GLY THR SER ILE TYR TYR ASN LYS ARG ILE LYS SEQRES 10 D 150 GLU ASN ALA ALA ALA ILE ALA TYR ASN ALA GLU ASN SER SEQRES 11 D 150 LEU PHE SER SER PRO VAL THR VAL ASP VAL HIS GLY LEU SEQRES 12 D 150 LEU PRO PRO LEU PRO PRO ALA HET NAG E 1 15 HET GAL E 2 11 HET FUC E 3 10 HET NAG F 1 15 HET GAL F 2 11 HET FUC F 3 10 HET NAG G 1 15 HET GAL G 2 11 HET FUC G 3 10 HET NAG H 1 15 HET GAL H 2 11 HET FUC H 3 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 5 GAL 4(C6 H12 O6) FORMUL 5 FUC 4(C6 H12 O5) FORMUL 9 HOH *339(H2 O) HELIX 1 1 PRO D 56 GLU D 58 5 3 SHEET 1 A 6 LEU A 2 LEU A 5 0 SHEET 2 A 6 VAL A 136 HIS A 141 -1 O VAL A 138 N TYR A 3 SHEET 3 A 6 VAL A 22 ARG A 26 -1 N VAL A 22 O HIS A 141 SHEET 4 A 6 SER A 90 ASP A 95 -1 O ILE A 91 N ILE A 25 SHEET 5 A 6 ARG A 99 ARG A 103 -1 O ARG A 103 N THR A 92 SHEET 6 A 6 ILE A 110 ASN A 113 -1 O ILE A 110 N ILE A 102 SHEET 1 B 6 ASN A 9 PHE A 17 0 SHEET 2 B 6 ALA A 120 ALA A 127 -1 O TYR A 125 N ASN A 9 SHEET 3 B 6 THR A 37 LEU A 42 -1 N ASN A 40 O ALA A 124 SHEET 4 B 6 ILE A 48 ARG A 55 -1 O ILE A 54 N THR A 37 SHEET 5 B 6 VAL A 60 ARG A 66 -1 O VAL A 62 N SER A 53 SHEET 6 B 6 GLU A 76 PRO A 79 -1 O GLU A 76 N PHE A 63 SHEET 1 C 6 LEU B 2 LEU B 5 0 SHEET 2 C 6 VAL B 136 HIS B 141 -1 O VAL B 138 N TYR B 3 SHEET 3 C 6 VAL B 22 ARG B 26 -1 N ARG B 26 O THR B 137 SHEET 4 C 6 SER B 90 ASP B 95 -1 O ILE B 91 N ILE B 25 SHEET 5 C 6 ARG B 99 ARG B 103 -1 O GLN B 101 N ILE B 94 SHEET 6 C 6 ILE B 110 ASN B 113 -1 O ILE B 110 N ILE B 102 SHEET 1 D 6 ASN B 9 PHE B 17 0 SHEET 2 D 6 ALA B 120 ALA B 127 -1 O ALA B 120 N PHE B 17 SHEET 3 D 6 THR B 37 LEU B 42 -1 N LEU B 42 O ALA B 121 SHEET 4 D 6 ILE B 48 ARG B 55 -1 O ILE B 54 N THR B 37 SHEET 5 D 6 VAL B 60 ARG B 66 -1 O ARG B 66 N ILE B 48 SHEET 6 D 6 GLU B 76 PRO B 79 -1 O GLU B 76 N PHE B 63 SHEET 1 E 6 LEU C 2 LEU C 5 0 SHEET 2 E 6 VAL C 136 HIS C 141 -1 O VAL C 138 N TYR C 3 SHEET 3 E 6 VAL C 22 ARG C 26 -1 N ARG C 26 O THR C 137 SHEET 4 E 6 SER C 90 ASP C 95 -1 O ILE C 91 N ILE C 25 SHEET 5 E 6 ARG C 99 ARG C 103 -1 O ARG C 103 N THR C 92 SHEET 6 E 6 ILE C 110 ASN C 113 -1 O ILE C 110 N ILE C 102 SHEET 1 F 6 ASN C 9 PHE C 17 0 SHEET 2 F 6 ALA C 120 ASN C 126 -1 O ALA C 120 N PHE C 17 SHEET 3 F 6 THR C 37 SER C 43 -1 N LEU C 42 O ALA C 121 SHEET 4 F 6 ILE C 48 ARG C 55 -1 O ILE C 54 N THR C 37 SHEET 5 F 6 VAL C 60 ARG C 66 -1 O VAL C 62 N SER C 53 SHEET 6 F 6 GLU C 76 PRO C 79 -1 O GLU C 76 N PHE C 63 SHEET 1 G 6 LEU D 2 LEU D 5 0 SHEET 2 G 6 VAL D 136 HIS D 141 -1 O VAL D 138 N TYR D 3 SHEET 3 G 6 VAL D 22 ARG D 26 -1 N VAL D 22 O HIS D 141 SHEET 4 G 6 SER D 90 ASP D 95 -1 O ILE D 91 N ILE D 25 SHEET 5 G 6 ARG D 99 ARG D 103 -1 O ARG D 103 N THR D 92 SHEET 6 G 6 ILE D 110 ASN D 113 -1 O ILE D 110 N ILE D 102 SHEET 1 H 6 ASN D 9 PHE D 17 0 SHEET 2 H 6 ALA D 120 ASN D 126 -1 O ALA D 120 N PHE D 17 SHEET 3 H 6 THR D 37 LEU D 42 -1 N VAL D 38 O ASN D 126 SHEET 4 H 6 ILE D 48 ARG D 55 -1 O ILE D 54 N THR D 37 SHEET 5 H 6 VAL D 60 ARG D 66 -1 O VAL D 62 N SER D 53 SHEET 6 H 6 GLU D 76 PRO D 79 -1 O ILE D 78 N ILE D 61 LINK O4 NAG E 1 C1 GAL E 2 1555 1555 1.38 LINK O2 GAL E 2 C1 FUC E 3 1555 1555 1.40 LINK O4 NAG F 1 C1 GAL F 2 1555 1555 1.38 LINK O2 GAL F 2 C1 FUC F 3 1555 1555 1.40 LINK O4 NAG G 1 C1 GAL G 2 1555 1555 1.38 LINK O2 GAL G 2 C1 FUC G 3 1555 1555 1.40 LINK O4 NAG H 1 C1 GAL H 2 1555 1555 1.38 LINK O2 GAL H 2 C1 FUC H 3 1555 1555 1.40 CISPEP 1 PRO A 86 PRO A 87 0 -0.28 CISPEP 2 SER A 134 PRO A 135 0 0.45 CISPEP 3 PRO B 86 PRO B 87 0 0.67 CISPEP 4 SER B 134 PRO B 135 0 -0.17 CISPEP 5 PRO C 86 PRO C 87 0 0.14 CISPEP 6 SER C 134 PRO C 135 0 0.36 CISPEP 7 PRO D 86 PRO D 87 0 0.38 CISPEP 8 SER D 134 PRO D 135 0 0.54 CRYST1 113.613 113.613 122.329 90.00 90.00 120.00 P 31 1 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008802 0.005082 0.000000 0.00000 SCALE2 0.000000 0.010163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008175 0.00000